Literature DB >> 15530848

Reactive oxygen species mediate RANK signaling in osteoclasts.

Hyunil Ha1, Han Bok Kwak, Soo Woong Lee, Hye Mi Jin, Hyun-Man Kim, Hong-Hee Kim, Zang Hee Lee.   

Abstract

RANKL, a member of tumor necrosis factor (TNF) superfamily, regulates the differentiation, activation, and survival of osteoclasts through binding to its cognate receptor, RANK. RANK can interact with several TNF-receptor-associated factors (TRAFs) and activates signaling molecules including Akt, NF-kappaB, and MAPKs. Although the transient elevation of reactive oxygen species (ROS) by receptor activation has been shown to act as a cellular secondary messenger, the involvement of ROS in RANK signaling pathways has been not characterized. In this study, we found that RANKL stimulated ROS generation in osteoclasts. Pretreatment of osteoclasts with the antioxidants N-acetyl-l-cystein and glutathione reduced RANKL-induced Akt, NF-kappaB, and ERK activation. The reduced NF-kappaB activity by antioxidants was associated with decreased IKK activity and IkappaBalpha phosphorylation. In contrast, antioxidants did not prevent TNF-alpha-induced Akt and NF-kappaB activation. Pretreatment with antioxidants also significantly reduced RANKL-induced actin ring formation, required for bone resorbing activity, and osteoclast survival. Taken together, our results suggest that ROS act as mediators in RANKL-induced signaling pathways and cellular events.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15530848     DOI: 10.1016/j.yexcr.2004.07.035

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  104 in total

1.  Simvastatin inhibits osteoclast differentiation by scavenging reactive oxygen species.

Authors:  Ho Jin Moon; Sung Eun Kim; Young Pil Yun; Yu Shik Hwang; Jae Beum Bang; Jae Hong Park; Il Keun Kwon
Journal:  Exp Mol Med       Date:  2011-11-30       Impact factor: 8.718

2.  Steap4 plays a critical role in osteoclastogenesis in vitro by regulating cellular iron/reactive oxygen species (ROS) levels and cAMP response element-binding protein (CREB) activation.

Authors:  Jian Zhou; Shiqiao Ye; Toshifumi Fujiwara; Stavros C Manolagas; Haibo Zhao
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

3.  Trolox prevents osteoclastogenesis by suppressing RANKL expression and signaling.

Authors:  Jong-Ho Lee; Ha-Neui Kim; Daum Yang; Kyoungsuk Jung; Hyun-Man Kim; Hong-Hee Kim; Hyunil Ha; Zang Hee Lee
Journal:  J Biol Chem       Date:  2009-03-19       Impact factor: 5.157

4.  The Quest for Osteoporosis Mechanisms and Rational Therapies: How Far We've Come, How Much Further We Need to Go.

Authors:  Stavros C Manolagas
Journal:  J Bone Miner Res       Date:  2018-02-22       Impact factor: 6.741

Review 5.  The immune system and bone.

Authors:  Roberto Pacifici
Journal:  Arch Biochem Biophys       Date:  2010-06-17       Impact factor: 4.013

6.  Deletion of ferroportin in murine myeloid cells increases iron accumulation and stimulates osteoclastogenesis in vitro and in vivo.

Authors:  Lei Wang; Bin Fang; Toshifumi Fujiwara; Kimberly Krager; Akshita Gorantla; Chaoyuan Li; Jian Q Feng; Michael L Jennings; Jian Zhou; Nukhet Aykin-Burns; Haibo Zhao
Journal:  J Biol Chem       Date:  2018-05-03       Impact factor: 5.157

7.  The role of oxidative stress in aseptic loosening of total hip arthroplasties.

Authors:  Marla J Steinbeck; Lauren J Jablonowski; Javad Parvizi; Theresa A Freeman
Journal:  J Arthroplasty       Date:  2013-11-26       Impact factor: 4.757

Review 8.  Diabetes and Its Effect on Bone and Fracture Healing.

Authors:  Hongli Jiao; E Xiao; Dana T Graves
Journal:  Curr Osteoporos Rep       Date:  2015-10       Impact factor: 5.096

9.  Water-soluble fullerene (C60) inhibits the osteoclast differentiation and bone destruction in arthritis.

Authors:  Kazuo Yudoh; Rie Karasawa; Kayo Masuko; Tomohiro Kato
Journal:  Int J Nanomedicine       Date:  2009-10-19

10.  Water-soluble fullerene (C60) inhibits the development of arthritis in the rat model of arthritis.

Authors:  Kazuo Yudoh; Rie Karasawa; Kayo Masuko; Tomohiro Kato
Journal:  Int J Nanomedicine       Date:  2009-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.